Product Program year 2025 Source: CMS Open Payments

CeQur Simplicity

Device Diabetes

PDI 00373108000006

Open in the dashboard

General payments

$1,362,276

11,007 payments

Research payments

$0

0 payments

Through program year 2025, $1,362,276 in general payments and $0 in research payments were reported against CeQur Simplicity (Diabetes).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $427,115 3,422
2024 General $420,098 3,430
2023 General $327,402 2,738
2022 General $187,660 1,417

Breakdown

Who paid General payments · program years 2022–2025
  1. CeQur Corporation $1,362,276 11,007 payments
Top recipients General payments · program year 2025
  1. Brian Levy Endocrinology, Diabetes & Metabolism · New York, NY $31,130 7% · 3 payments
  2. Michael Valitutto Internal Medicine · Kalamazoo, MI $11,870 3% · 3 payments
  3. Andrew Adams Internal Medicine · Saxonburg, PA $11,293 3% · 2 payments
  4. Vinay Kapoor Endocrinology, Diabetes & Metabolism · Manhasset, NY $9,000 2% · 3 payments
  5. Jonathan Velez Rivera Endocrinology, Diabetes & Metabolism · Orlando, FL $8,211 2% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Endocrinology, Diabetes & Metabolism Internal Medicine $210,557 50% · 956 practitioners
  2. Internal Medicine $50,100 12% · 348 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $49,389 12% · 618 practitioners
  4. Physician Assistant $26,501 6% · 314 practitioners
  5. Physician Assistant, Medical Physician Assistant $21,857 5% · 108 practitioners

The top 5 of 66 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $65,336 15% · 174 recipients
  2. Pennsylvania $44,645 10% · 279 recipients
  3. Texas $42,456 10% · 363 recipients
  4. Florida $39,513 9% · 250 recipients
  5. Tennessee $33,733 8% · 278 recipients

The top 5 of 46 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

11,007 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record